Peripheral inflammation is a potential etiological factor in Alzheimer's disease
- PMID: 37602685
- DOI: 10.1515/revneuro-2023-0049
Peripheral inflammation is a potential etiological factor in Alzheimer's disease
Abstract
Peripheral inflammation could constitute a risk factor for AD. This review summarizes the research related to peripheral inflammation that appears to have a relationship with Alzheimer's disease. We find there are significant associations between AD and peripheral infection induced by various pathogens, including herpes simplex virus type 1, cytomegalovirus, Epstein-Barr virus, human immunodeficiency virus, severe acute respiratory syndrome coronavirus 2, Porphyromonas gingivalis, Helicobacter pylori, and Toxoplasma gondii. Chronic inflammatory diseases are also reported to contribute to the pathophysiology of AD. The mechanisms by which peripheral inflammation affects the pathophysiology of AD are complex. Pathogen-derived neurotoxic molecule composition, disrupted BBB, and dysfunctional neurogenesis may all play a role in peripheral inflammation, promoting the development of AD. Anti-pathogenic medications and anti-inflammatory treatments are reported to decrease the risk of AD. Studies that could improve understanding the associations between AD and peripheral inflammation are needed. If our assumption is correct, early intervention against inflammation may be a potential method of preventing and treating AD.
Keywords: Alzheimer’s disease; amyloid; neuroinflammation; pathogen; peripheral inflammation.
© 2023 Walter de Gruyter GmbH, Berlin/Boston.
Similar articles
-
Infectious agents and Alzheimer's disease.J Integr Neurosci. 2022 Mar 28;21(2):73. doi: 10.31083/j.jin2102073. J Integr Neurosci. 2022. PMID: 35364661 Review.
-
Friends and Foes in Alzheimer's Disease.Med Princ Pract. 2023;32(6):313-322. doi: 10.1159/000534400. Epub 2023 Oct 3. Med Princ Pract. 2023. PMID: 37788649 Free PMC article. Review.
-
Alzheimer's disease and infectious agents: a comprehensive review of pathogenic mechanisms and microRNA roles.Front Neurosci. 2025 Jan 7;18:1513095. doi: 10.3389/fnins.2024.1513095. eCollection 2024. Front Neurosci. 2025. PMID: 39840010 Free PMC article. Review.
-
Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease.J Alzheimers Dis. 2015;48(2):319-53. doi: 10.3233/JAD-142853. J Alzheimers Dis. 2015. PMID: 26401998 Free PMC article. Review.
-
[Herpesvirus infections and immunological disturbances in patients with different stages of Alzheimer's disease].Vopr Virusol. 2021 May 15;66(2):129-139. doi: 10.36233/0507-4088-32. Vopr Virusol. 2021. PMID: 33993683 Russian.
Cited by
-
Association of choroid plexus volume with white matter microstructure, glymphatic function, and peripheral systemic inflammation in Alzheimer's disease.Transl Psychiatry. 2025 Jul 11;15(1):238. doi: 10.1038/s41398-025-03432-1. Transl Psychiatry. 2025. PMID: 40645956 Free PMC article.
-
The intersection of delirium and long-term cognition in older adults: the critical role of delirium prevention.J Neurol. 2025 May 6;272(6):381. doi: 10.1007/s00415-025-13104-1. J Neurol. 2025. PMID: 40329080 Review.
-
Elevated C-Reactive Protein in Older Men With Chronic Pain: Association With Plasma Amyloid Levels and Hippocampal Volume.J Gerontol A Biol Sci Med Sci. 2024 Nov 1;79(11):glae206. doi: 10.1093/gerona/glae206. J Gerontol A Biol Sci Med Sci. 2024. PMID: 39169831 Free PMC article.
-
A Gut Microbial Metabolite Alleviates Stress-Induced Neurobehavioral Dysfunction in an Alzheimer's Disease Model.Mol Neurobiol. 2025 Sep;62(9):11666-11680. doi: 10.1007/s12035-025-04960-z. Epub 2025 May 1. Mol Neurobiol. 2025. PMID: 40310548
-
Post-symptomatic NLRP3 inhibition rescues cognitive impairment and mitigates amyloid and tau driven neurodegeneration.NPJ Dement. 2025;1(1):3. doi: 10.1038/s44400-025-00011-5. Epub 2025 May 6. NPJ Dement. 2025. PMID: 40343261 Free PMC article.
References
-
- Acuña, L., Hamadat, S., Corbalán, N.S., González-Lizárraga, F., Dos-Santos-Pereira, M., Rocca, J., Díaz, J.S., Del-Bel, E., Papy-García, D., Chehín, R.N., et al. (2019). Rifampicin and its derivative rifampicin quinone reduce microglial inflammatory responses and neurodegeneration induced in vitro by α-synuclein aggregates. Cells 8: 766, https://doi.org/10.3390/cells8080776 . - DOI
-
- Aisen, P.S., Schmeidler, J., and Pasinetti, G.M. (2002). Randomized pilot study of nimesulide treatment in Alzheimer’s disease. Neurology 58: 1050–1054, https://doi.org/10.1212/wnl.58.7.1050 . - DOI
-
- Aksenov, M.Y., Aksenova, M.V., Mactutus, C.F., and Booze, R.M. (2010). HIV-1 protein-mediated amyloidogenesis in rat hippocampal cell cultures. Neurosci. Lett. 475: 174–178, https://doi.org/10.1016/j.neulet.2010.03.073 . - DOI
-
- Aktas, O., Ullrich, O., Infante-Duarte, C., Nitsch, R., and Zipp, F. (2007). Neuronal damage in brain inflammation. Arch. Neurol. 64: 185–189, https://doi.org/10.1001/archneur.64.2.185 . - DOI
-
- Albornoz, E.A., Woodruff, T.M., and Gordon, R. (2018). Inflammasomes in CNS diseases. Exper. Suppl. 108: 41–60, https://doi.org/10.1007/978-3-319-89390-7_3 . - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical